MENS Jyong Biotech Ltd. Ordinary Shares
Healthcare$2.15+3.37%ClosedMarket Cap: $163.5M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-6.41
P/S
0.00
EV/EBITDA
-68.86
DCF Value
$-0.08
FCF Yield
-0.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
19.7%
ROA
-22.5%
ROIC
46.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $0.00 | NaN% | $-1.8M | $-3.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-2.6M | $-4.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-816.0K | $-1.3M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-552.50 | $-846.50 | $— | — |
| FY null | $0.00 | -Infinity% | $-2.1M | $-3.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-552.50 | $-846.50 | $— | — |
| Q2 null | $0.00 | -Infinity% | $-475.50 | $-663.00 | $— | — |
| Q1 null | $0.00 | NaN% | $-475.50 | $-663.00 | $— | — |
| Q4 null | $0.00 | NaN% | $-844.00 | $-1.3K | $— | — |
| FY null | $0.00 | -Infinity% | $-2.8M | $-4.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-2.8M | $-6.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-2.4M | $-4.2M | $— | — |